偏头痛非药物防治中国专家共识

2021-01-20 中国神经内科相关专家小组(统称) 神经损伤与功能重建.2021.16(1):1-5.

目前,中国偏头痛呈现发病率高、致残率高、40~44 岁时疾病负担达到高峰、女性高于男性的趋势。许多偏头痛患者对药物治疗依从性差、疗效欠佳、或不能耐受不良反应,导致急性镇痛药的滥用和头痛的慢性化。能够推

中文标题:

偏头痛非药物防治中国专家共识

发布日期:

2021-01-20

简要介绍:

目前,中国偏头痛呈现发病率高、致残率高、40~44 岁时疾病负担达到高峰、女性高于男性的趋势。许多偏头痛患者对药物治疗依从性差、疗效欠佳、或不能耐受不良反应,导致急性镇痛药的滥用和头痛的慢性化。能够推荐给儿童和妊娠期偏头痛患者的药物极其有限。随着对偏头痛认识的不断深入和非药物防治经验的积累,以针灸为主的非药物治疗策略在偏头痛的防治中发挥了重要作用。对于不适合药物治疗的偏头痛患者,应推荐非药物防治策略。为规范我国广大医生对偏头痛的非药物防治方法,本共识经中西医结合专家讨论,针对无/有先兆偏头痛的急性发作期和间歇期,确定推荐调整生活方式、针灸疗法、神经调节技术、行为疗法四大类非药物防治方法,以供临床医生参考。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=偏头痛非药物防治中国专家共识_于生元.pdf)] GetToolGuiderByIdResponse(projectId=1, id=42be91c0020a49b9, title=偏头痛非药物防治中国专家共识, enTitle=, guiderFrom=神经损伤与功能重建.2021.16(1):1-5., authorId=0, author=, summary=目前,中国偏头痛呈现发病率高、致残率高、40~44 岁时疾病负担达到高峰、女性高于男性的趋势。许多偏头痛患者对药物治疗依从性差、疗效欠佳、或不能耐受不良反应,导致急性镇痛药的滥用和头痛的慢性化。能够推, cover=https://img.medsci.cn/2021129/1611894152680_2020535.jpg, journalId=0, articlesId=null, associationId=724, associationName=中国神经内科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Wed Jan 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>目前,中国偏头痛呈现发病率高、致残率高、40~44 岁时疾病负担达到高峰、女性高于男性的趋势。许多偏头痛患者对药物治疗依从性差、疗效欠佳、或不能耐受不良反应,导致急性镇痛药的滥用和头痛的慢性化。能够推荐给儿童和妊娠期偏头痛患者的药物极其有限。随着对偏头痛认识的不断深入和非药物防治经验的积累,以针灸为主的非药物治疗策略在偏头痛的防治中发挥了重要作用。对于不适合药物治疗的偏头痛患者,应推荐非药物防治策略。为规范我国广大医生对偏头痛的非药物防治方法,本共识经中西医结合专家讨论,针对无/有先兆偏头痛的急性发作期和间歇期,确定推荐调整生活方式、针灸疗法、神经调节技术、行为疗法四大类非药物防治方法,以供临床医生参考。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1305, tagName=偏头痛)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21049, categoryName=偏头痛网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1305, guiderKeyword=偏头痛, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7821, appHits=440, showAppHits=0, pcHits=1109, showPcHits=7380, likes=1, shares=33, comments=22, approvalStatus=1, publishedTime=Fri Jan 29 12:24:07 CST 2021, publishedTimeString=2021-01-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Fri Jan 29 12:22:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 21:04:04 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=偏头痛非药物防治中国专家共识_于生元.pdf)])
偏头痛非药物防治中国专家共识_于生元.pdf
下载请点击:
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1072291, encodeId=35c310e2291d1, content=谢谢及时分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:05:53 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061609, encodeId=489a106160922, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Mon Oct 18 21:04:49 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016581, encodeId=897a1016581dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69001567957, createdName=cuijiexx, createdTime=Sat Sep 11 16:22:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007909, encodeId=7228100e909d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211115/912457d765c64bf98260d14e48ef3eae/c318e6ed1c1f4f9c81f1459ed6880736.jpg, createdBy=b9455573275, createdName=unknown66, createdTime=Sat Aug 14 20:56:57 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999537, encodeId=2dd399953e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Jul 14 21:19:46 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-11-20 120d521dm50暂无昵称

    谢谢及时分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1072291, encodeId=35c310e2291d1, content=谢谢及时分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:05:53 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061609, encodeId=489a106160922, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Mon Oct 18 21:04:49 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016581, encodeId=897a1016581dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69001567957, createdName=cuijiexx, createdTime=Sat Sep 11 16:22:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007909, encodeId=7228100e909d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211115/912457d765c64bf98260d14e48ef3eae/c318e6ed1c1f4f9c81f1459ed6880736.jpg, createdBy=b9455573275, createdName=unknown66, createdTime=Sat Aug 14 20:56:57 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999537, encodeId=2dd399953e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Jul 14 21:19:46 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-10-18 ms3000001999686436

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1072291, encodeId=35c310e2291d1, content=谢谢及时分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:05:53 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061609, encodeId=489a106160922, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Mon Oct 18 21:04:49 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016581, encodeId=897a1016581dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69001567957, createdName=cuijiexx, createdTime=Sat Sep 11 16:22:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007909, encodeId=7228100e909d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211115/912457d765c64bf98260d14e48ef3eae/c318e6ed1c1f4f9c81f1459ed6880736.jpg, createdBy=b9455573275, createdName=unknown66, createdTime=Sat Aug 14 20:56:57 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999537, encodeId=2dd399953e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Jul 14 21:19:46 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-09-11 cuijiexx

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1072291, encodeId=35c310e2291d1, content=谢谢及时分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:05:53 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061609, encodeId=489a106160922, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Mon Oct 18 21:04:49 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016581, encodeId=897a1016581dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69001567957, createdName=cuijiexx, createdTime=Sat Sep 11 16:22:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007909, encodeId=7228100e909d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211115/912457d765c64bf98260d14e48ef3eae/c318e6ed1c1f4f9c81f1459ed6880736.jpg, createdBy=b9455573275, createdName=unknown66, createdTime=Sat Aug 14 20:56:57 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999537, encodeId=2dd399953e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Jul 14 21:19:46 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-08-14 unknown66

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1072291, encodeId=35c310e2291d1, content=谢谢及时分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d3b2210771, createdName=120d521dm50暂无昵称, createdTime=Sat Nov 20 18:05:53 CST 2021, time=2021-11-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061609, encodeId=489a106160922, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0e335570578, createdName=ms3000001999686436, createdTime=Mon Oct 18 21:04:49 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1016581, encodeId=897a1016581dd, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=69001567957, createdName=cuijiexx, createdTime=Sat Sep 11 16:22:04 CST 2021, time=2021-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007909, encodeId=7228100e909d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211115/912457d765c64bf98260d14e48ef3eae/c318e6ed1c1f4f9c81f1459ed6880736.jpg, createdBy=b9455573275, createdName=unknown66, createdTime=Sat Aug 14 20:56:57 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999537, encodeId=2dd399953e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Jul 14 21:19:46 CST 2021, time=2021-07-14, status=1, ipAttribution=)]
    2021-07-14 ms5000001266883663

    学习了

    0

拓展阅读

EFNS指南:离子通道病、癫痫、偏头痛、卒中和痴呆的分子诊断

欧洲神经科学协会联盟(EFNS,European Federation of Neurological Societies) · 2010-01-01

偏头痛、紧张型头痛、丛集性头痛、药物过度使用头痛的所有医疗专业人员的诊治指南

英国头痛研究学会(BASH,British Association for the study of Headache) · 2010-03-07

2011 中国偏头痛诊断治疗指南

中华医学会疼痛学分会头面痛学组 · 2011-02-01

偏头痛药物对照试验指南:第3版

国际头痛协会(IHS,International Headache society) · 2012-01-01

2012 AAN 成人阵发性偏头痛预防药物治疗循证指南

美国神经病学学会(AAN,American Academy of Neurology) · 2012-04-24

2012AAN NSAID和其他补充剂防治成人发作性偏头痛循证指南

美国神经病学学会(AAN,American Academy of Neurology) · 2012-04-24